For the second time, the interactive advanced training event" Small Airways Summit ", initiated by the Chiesi company and chaired by the German Small Airways Expert Group (DESA), took place. A large number of recognized national and international speakers highlighted the importance of the small airways in asthma and COPD from different perspectives. Inflammation and obstruction of the small airways are decisive pathophysiological and prognostically relevant factor in asthma and COPD: "The inflammatory music plays in the small airways," said Dr. med. Thomas Voshaar, Moers, Chairman of the event. If triple therapy is required in the course of COPD, the muscarinic receptor antagonist (LAMA) glycopyrronium could be good partner for fixed combination with ICS / LABA. As an innovative and researching respiratory expert, the further development of COPD therapy is an important concern for Chiesi.
Source: Chiesi GmbH, www.chiesi.de